Last reviewed · How we verify

NCT04438447: RASTA

ERAS Versus ERAS Plus Artificial Nutrition in Open Pancreatoduodenectomy

Status unknown NA Last updated 5 December 2022
What this trial tests

NA trial testing parenteral feeding in Pancreas Disease in 240 participants. Status unknown.

Timeline
14 April 2022
Primary endpoint
10 September 2022
31 December 2022

Quick facts

Lead sponsorUniversity of Milano Bicocca
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment240
Start date14 April 2022
Primary completion10 September 2022
Estimated completion31 December 2022
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Milano Bicocca

Who can join

Adults 18 to 90, any sex, with Pancreas Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

there is a need of a randomised clinical trial specifically design to explore whether given a full nutritional requirement by parenteral feeding in the first 5 days after surgery coupled with oral food "at will" compared to only oral food "at will", within an established ERAS program, could achieve a reduction of the morbidity burden

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Supplemental parenteral nutrition within an enhanced recovery program for open pancreatoduodenectomy for cancer: a pragmatic, multicenter, randomized controlled trial.
    Gianotti L, Paiella S, Capretti G, Pecorelli N, et al · · 2025 · cited 1× · PMID 40896466 · DOI 10.1016/j.eclinm.2025.103455
  2. ERAS with or without supplemental artificial nutrition in open pancreatoduodenectomy for cancer. A multicenter, randomized, open labeled trial (RASTA study protocol).
    Gianotti L, Paiella S, Frigerio I, Pecorelli N, et al · · 2023 · cited 1× · PMID 37051129 · DOI 10.3389/fnut.2023.1113723
  3. Construct Validity and Reliability of the Comprehensive Complication Index as a Morbidity Outcome Measure in Pancreatic Surgery.
    Pecorelli N, Fermi F, Abbassi F, Bannone E, et al · · 2025 · PMID 41403005 · DOI 10.1097/sla.0000000000007002

Verify or expand the search:

Other recruiting trials for Pancreas Disease

Currently open trials in the same condition.

Other University of Milano Bicocca trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04438447.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing